morpholine has been researched along with purine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, R; Liu, ZH; Wang, NY; Wang, WL; Xu, Y; Yu, LT; Zhu, YX; Zuo, WQ | 1 |
| Ban, Ž; Glavaš-Obrovac, L; Ismaili, H; Jukić, M; Matić, J; Opačak-Bernardi, T; Saftić, D; Tandarić, T; Vianello, R; Žinić, B | 1 |
2 other study(ies) available for morpholine and purine
| Article | Year |
|---|---|
Identification of a potent and selective phosphatidylinositol 3-kinase δ inhibitor for the treatment of non-Hodgkin's lymphoma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Enzyme Inhibitors; Heterografts; Humans; Lymphoma, Non-Hodgkin; Mice, SCID; Mitogen-Activated Protein Kinase Kinases; Molecular Docking Simulation; Morpholines; Neoplasms, Experimental; Phosphatidylinositol 3-Kinases; Phosphorylation; Piperazines; Purines | 2020 |
6-Morpholino- and 6-amino-9-sulfonylpurine derivatives. Synthesis, computational analysis, and biological activity.
Topics: Antineoplastic Agents; Cell Cycle; Cell Line; Cell Proliferation; Density Functional Theory; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Morpholines; Purines | 2021 |